Cargando…
Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials.
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414593/ https://www.ncbi.nlm.nih.gov/pubmed/32573724 http://dx.doi.org/10.1182/blood.2020007079 |
_version_ | 1783568998727680000 |
---|---|
author | Xia, Xinyi Li, Kening Wu, Lingxiang Wang, Zhihua Zhu, Mengyan Huang, Bin Li, Jie Wang, Ziyu Wu, Wei Wu, Min Li, Wanlin Li, Lu Cai, Yun Bosco, Bakwatanisa Zhong, Aifang Liu, Xiong Lv, Tangfeng Gan, Zhenhua Chen, Guang Pan, Yunhu Liu, Caidong Zhang, Kai Xu, Xiaoli Wang, Changjun Wang, Qianghu |
author_facet | Xia, Xinyi Li, Kening Wu, Lingxiang Wang, Zhihua Zhu, Mengyan Huang, Bin Li, Jie Wang, Ziyu Wu, Wei Wu, Min Li, Wanlin Li, Lu Cai, Yun Bosco, Bakwatanisa Zhong, Aifang Liu, Xiong Lv, Tangfeng Gan, Zhenhua Chen, Guang Pan, Yunhu Liu, Caidong Zhang, Kai Xu, Xiaoli Wang, Changjun Wang, Qianghu |
author_sort | Xia, Xinyi |
collection | PubMed |
description | Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials. |
format | Online Article Text |
id | pubmed-7414593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-74145932020-09-09 Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion Xia, Xinyi Li, Kening Wu, Lingxiang Wang, Zhihua Zhu, Mengyan Huang, Bin Li, Jie Wang, Ziyu Wu, Wei Wu, Min Li, Wanlin Li, Lu Cai, Yun Bosco, Bakwatanisa Zhong, Aifang Liu, Xiong Lv, Tangfeng Gan, Zhenhua Chen, Guang Pan, Yunhu Liu, Caidong Zhang, Kai Xu, Xiaoli Wang, Changjun Wang, Qianghu Blood Letter to Blood Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials. American Society of Hematology 2020-08-06 2020-12-14 /pmc/articles/PMC7414593/ /pubmed/32573724 http://dx.doi.org/10.1182/blood.2020007079 Text en Copyright © 2020 American Society of Hematology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to Blood Xia, Xinyi Li, Kening Wu, Lingxiang Wang, Zhihua Zhu, Mengyan Huang, Bin Li, Jie Wang, Ziyu Wu, Wei Wu, Min Li, Wanlin Li, Lu Cai, Yun Bosco, Bakwatanisa Zhong, Aifang Liu, Xiong Lv, Tangfeng Gan, Zhenhua Chen, Guang Pan, Yunhu Liu, Caidong Zhang, Kai Xu, Xiaoli Wang, Changjun Wang, Qianghu Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion |
title | Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion |
title_full | Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion |
title_fullStr | Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion |
title_full_unstemmed | Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion |
title_short | Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion |
title_sort | improved clinical symptoms and mortality among patients with severe or critical covid-19 after convalescent plasma transfusion |
topic | Letter to Blood |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414593/ https://www.ncbi.nlm.nih.gov/pubmed/32573724 http://dx.doi.org/10.1182/blood.2020007079 |
work_keys_str_mv | AT xiaxinyi improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT likening improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT wulingxiang improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT wangzhihua improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT zhumengyan improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT huangbin improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT lijie improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT wangziyu improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT wuwei improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT wumin improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT liwanlin improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT lilu improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT caiyun improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT boscobakwatanisa improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT zhongaifang improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT liuxiong improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT lvtangfeng improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT ganzhenhua improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT chenguang improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT panyunhu improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT liucaidong improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT zhangkai improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT xuxiaoli improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT wangchangjun improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion AT wangqianghu improvedclinicalsymptomsandmortalityamongpatientswithsevereorcriticalcovid19afterconvalescentplasmatransfusion |